Nitroglycerin

Generic Name
Nitroglycerin
Brand Names
Gonitro, Minitran, Mylan-nitro, Nitro-bid, Nitro-dur, Nitroject, Nitrolingual, Nitromist, Nitrostat, Rectiv, Trinipatch
Drug Type
Small Molecule
Chemical Formula
C3H5N3O9
CAS Number
55-63-0
Unique Ingredient Identifier
G59M7S0WS3
Background

Nitroglycerin, also known as glyceryl trinitrate, is an organic nitrate and a vasodilating agent that was first discovered in 1847. Originally used to dynamite, its antianginal effects were identified in the late 1860s after it produced headaches in factory workers while workers with angina pectoris or heart failure experienced relief from chest pain. Its u...

Indication

Sublingual nitroglycerin is indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease. Transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease.
...

Associated Conditions
Angina Attacks, Angina Pectoris, Congestive Heart Failure (CHF), Perioperative Hypertension, Moderate to severe pain
Associated Therapies
-

Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients With CSFP

First Posted Date
2017-09-28
Last Posted Date
2020-03-12
Lead Sponsor
RenJi Hospital
Target Recruit Count
57
Registration Number
NCT03296670
Locations
🇨🇳

Ren Ji Hospital Afflited to School of Medicine, Shanghai Jiao Tong University, ShangHai, China

Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients Undergoing Primary PCI

First Posted Date
2017-08-17
Last Posted Date
2017-08-17
Lead Sponsor
RenJi Hospital
Target Recruit Count
600
Registration Number
NCT03252665
Locations
🇨🇳

Ren Ji Hospital Afflited to School of Medicine, Shanghai Jiao Tong University, ShangHai, China

Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality

Phase 4
Completed
Conditions
Interventions
First Posted Date
2016-11-11
Last Posted Date
2019-09-17
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
198
Registration Number
NCT02961946
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

The Role of Nitric Oxide in Cognition in Schizophrenia

First Posted Date
2016-09-20
Last Posted Date
2019-08-13
Lead Sponsor
King's College London
Target Recruit Count
19
Registration Number
NCT02906553
Locations
🇬🇧

South London and Maudsley, London, United Kingdom

Vericiguat Drug-drug Interaction With Nitroglycerin in Stable Coronary Artery Disease Patients

First Posted Date
2015-12-01
Last Posted Date
2021-12-29
Lead Sponsor
Bayer
Target Recruit Count
36
Registration Number
NCT02617550

Topical Glyceryl Trinitrate (GTN) and Eccentric Exercises in the Treatment of Midportion Achilles Tendinopathy

First Posted Date
2015-07-16
Last Posted Date
2019-06-06
Lead Sponsor
Royal College of Surgeons, Ireland
Target Recruit Count
76
Registration Number
NCT02499484
Locations
🇮🇪

Connolly Hospital, Blanchardstown, Dublin, Ireland

Clinical Trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)

First Posted Date
2015-07-13
Last Posted Date
2020-02-12
Lead Sponsor
Futura Medical Developments Ltd.
Target Recruit Count
232
Registration Number
NCT02495467
Locations
🇬🇧

Richmond Pharmacology Ltd., Croydon, Surrey, United Kingdom

Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension

Phase 1
Active, not recruiting
Conditions
Interventions
First Posted Date
2015-04-24
Last Posted Date
2024-08-09
Lead Sponsor
Vanderbilt University
Target Recruit Count
12
Registration Number
NCT02425566
Locations
🇺🇸

Autonomic Dysfunction Center, Nashville, Tennessee, United States

Topical Nitroglycerin To Prevent Radial Artery Occlusion After Transradial Access: NTP-RAO Trial

First Posted Date
2015-04-09
Last Posted Date
2019-09-17
Lead Sponsor
Total Cardiovascular Solutions
Target Recruit Count
2400
Registration Number
NCT02413268
Locations
🇮🇳

Apex Heart Institute, Ahmedabad, Gujarat, India

Randomized Clinical Trial Comparing Transradial Catheterization With or Without Spasmolytic Drugs

Phase 3
Completed
Conditions
Interventions
First Posted Date
2015-01-21
Last Posted Date
2019-05-31
Lead Sponsor
Instituto de Cardiologia de Santa Catarina
Target Recruit Count
328
Registration Number
NCT02343276
Locations
🇧🇷

Instituto de Cardiologia de Santa Catarina, São Jose, SC, Brazil

© Copyright 2024. All Rights Reserved by MedPath